Global Hypercalcemia Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1240

Hypercalcemia is a condition caused by above normal levels of calcium in the body, with serum calcium level greater than 2.6 mmol/L. It is a life threatening metabolic disorder associated with neoplastic diseases and occurs in 10% to 20% of all adults suffering from cancer; particularly lung and breast cancer, and myeloma.
The increasing instances of surgical procedures, such as hip and knee replacements, will increase the risk of hypercalcemia and drive the growth prospects for the global hypercalcemia treatment market in the upcoming years. The study also shows that the prevalence of broken bone repair surgeries, cardiovascular procedures, percutaneous coronary interventions, joint replacement surgeries, knee replacement surgeries, hip replacement surgeries, and cases of coronary artery bypass grafting will increase the chances of developing hypercalcemia post surgeries. Consequently, the demand for hypercalcemia treatment drugs will also increase during the predicted period.
The growing preference for combination therapy is estimated to drive the growth prospects for the global hypercalcemia treatment market until the end of 2023. The adoption rate and preference for hypercalcemia drugs is increasing in developed countries with the growing use of hypercalcemia drugs in combination with other therapies. For instance, researchers have evaluated the use of combination drugs, which includes pamidronate and calcitonin. Additionally, it has also been observed that the reduction in elevated serum parathyroid hormone (PTH) levels and the improvement of bone mineral density can be achieved using denosumab (DMAb) and calcitriol. Such combination therapies will lead to a new therapeutic strategy to reverse severe bone loss due to therapy-resistant SHPT in individuals with CKD.
In 2018, the global Hypercalcemia Treatment market size was 8590 million US$ and it is expected to reach 19100 million US$ by the end of 2025, with a CAGR of 10.5% during 2019-2025.

This report focuses on the global Hypercalcemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hypercalcemia Treatment development in United States, Europe and China.

The key players covered in this study
AbbVie
Amgen
Merck
Novartis
OPKO Health
...

Market segment by Type, the product can be split into
Bisphosphonates
Glucocorticoids
Calcimimetic Agents

Market segment by Application, split into
Mild Hypercalcemia 
Moderate Hypercalcemia 
Severe Hypercalcemia

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hypercalcemia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Hypercalcemia Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hypercalcemia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hypercalcemia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Bisphosphonates
1.4.3 Glucocorticoids
1.4.4 Calcimimetic Agents
1.5 Market by Application
1.5.1 Global Hypercalcemia Treatment Market Share by Application (2014-2025)
1.5.2 Mild Hypercalcemia 
1.5.3 Moderate Hypercalcemia 
1.5.4 Severe Hypercalcemia
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hypercalcemia Treatment Market Size
2.2 Hypercalcemia Treatment Growth Trends by Regions
2.2.1 Hypercalcemia Treatment Market Size by Regions (2014-2025)
2.2.2 Hypercalcemia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Hypercalcemia Treatment Market Size by Manufacturers
3.1.1 Global Hypercalcemia Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Hypercalcemia Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hypercalcemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Hypercalcemia Treatment Key Players Head office and Area Served
3.3 Key Players Hypercalcemia Treatment Product/Solution/Service
3.4 Date of Enter into Hypercalcemia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hypercalcemia Treatment Market Size by Type (2014-2019)
4.2 Global Hypercalcemia Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Hypercalcemia Treatment Market Size (2014-2019)
5.2 Hypercalcemia Treatment Key Players in United States
5.3 United States Hypercalcemia Treatment Market Size by Type
5.4 United States Hypercalcemia Treatment Market Size by Application

6 Europe
6.1 Europe Hypercalcemia Treatment Market Size (2014-2019)
6.2 Hypercalcemia Treatment Key Players in Europe
6.3 Europe Hypercalcemia Treatment Market Size by Type
6.4 Europe Hypercalcemia Treatment Market Size by Application

7 China
7.1 China Hypercalcemia Treatment Market Size (2014-2019)
7.2 Hypercalcemia Treatment Key Players in China
7.3 China Hypercalcemia Treatment Market Size by Type
7.4 China Hypercalcemia Treatment Market Size by Application

8 Japan
8.1 Japan Hypercalcemia Treatment Market Size (2014-2019)
8.2 Hypercalcemia Treatment Key Players in Japan
8.3 Japan Hypercalcemia Treatment Market Size by Type
8.4 Japan Hypercalcemia Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hypercalcemia Treatment Market Size (2014-2019)
9.2 Hypercalcemia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Hypercalcemia Treatment Market Size by Type
9.4 Southeast Asia Hypercalcemia Treatment Market Size by Application

10 India
10.1 India Hypercalcemia Treatment Market Size (2014-2019)
10.2 Hypercalcemia Treatment Key Players in India
10.3 India Hypercalcemia Treatment Market Size by Type
10.4 India Hypercalcemia Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Hypercalcemia Treatment Market Size (2014-2019)
11.2 Hypercalcemia Treatment Key Players in Central & South America
11.3 Central & South America Hypercalcemia Treatment Market Size by Type
11.4 Central & South America Hypercalcemia Treatment Market Size by Application

12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hypercalcemia Treatment Introduction
12.1.4 AbbVie Revenue in Hypercalcemia Treatment Business (2014-2019)
12.1.5 AbbVie Recent Development
12.2 Amgen
12.2.1 Amgen Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hypercalcemia Treatment Introduction
12.2.4 Amgen Revenue in Hypercalcemia Treatment Business (2014-2019)
12.2.5 Amgen Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hypercalcemia Treatment Introduction
12.3.4 Merck Revenue in Hypercalcemia Treatment Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hypercalcemia Treatment Introduction
12.4.4 Novartis Revenue in Hypercalcemia Treatment Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 OPKO Health
12.5.1 OPKO Health Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hypercalcemia Treatment Introduction
12.5.4 OPKO Health Revenue in Hypercalcemia Treatment Business (2014-2019)
12.5.5 OPKO Health Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details